Cancer Biosimilars Associated With Lower Costs for Insurers and Patients, UCLA Study Finds
August 28, 2026
August 28, 2026
LOS ANGELES, California, Aug. 28 (TNSjou) -- The UCLA Health Jonsson Comprehensive Cancer Center issued the following news release:
* * *
Cancer biosimilars associated with lower costs for insurers and patients, UCLA study finds
Analysis of more than 14,000 patient-drug pairs found biosimilar use was associated with lower costs and declining use of original branded biologic drugs
-
Biologic drugs play an important role in treating . . .
* * *
Cancer biosimilars associated with lower costs for insurers and patients, UCLA study finds
Analysis of more than 14,000 patient-drug pairs found biosimilar use was associated with lower costs and declining use of original branded biologic drugs
-
Biologic drugs play an important role in treating . . .